Maltese Maltese
en Englishaf Afrikaanssq Albanianar Arabichy Armenianaz Azerbaijanieu Basquebe Belarusianbg Bulgarianca Catalanzh-CN Chinese (Simplified)zh-TW Chinese (Traditional)hr Croatiancs Czechda Danishnl Dutchet Estoniantl Filipinofi Finnishfr Frenchgl Galicianka Georgiande Germanel Greekht Haitian Creoleiw Hebrewhi Hindihu Hungarianis Icelandicid Indonesianga Irishit Italianja Japaneseko Koreanlv Latvianlt Lithuanianmk Macedonianms Malaymt Malteseno Norwegianfa Persianpl Polishpt Portuguesero Romanianru Russiansr Serbiansk Slovaksl Slovenianes Spanishsw Swahilisv Swedishth Thaitr Turkishuk Ukrainianur Urduvi Vietnamesecy Welshyi Yiddish

podcasts

L-ewwel Parti: Immunità li teżisti minn qabel Kontra s-Serotipi AAV u X'Inhu Mezz għat-Terapiji Kliniċi tat-Terapija tal-Ġene tal-Emofilja

Ippreżentat minn Steven W. Pipe, MD u Nigel Key, MB, ChB. FRCP

Trasferiment tal-Ġene medjat mill-Virus Adeno-Assoċjat (AAV): Għaliex hi din l-Istrateġija Predominanti għat-Terapija tal-Ġeni tal-Emofilja?

Ippreżentat minn Steven W. Pipe, MD u Nigel Key, MB, ChB. FRCP

Monitoraġġ fit-Term Wara t-Terapija tal-Ġeni tal-Emofilja

Ippreżentat minn Steven W. Pipe, MD u Nigel Key, MB, ChB. FRCP

Punti ewlenin mill-15-il Workshop tal-NHF dwar Teknoloġiji ta 'Ġdid u Trasferiment ta' Ġeni għall-Emofilja

Preżentat minn David Lillicrap, MD u Glenn F. Peirce, MD, PhD

Grupp ta 'Ħidma dwar it-Terapija tal-Ġeni EAHAD

Ippreżentat minn Wolfgang Miesbach, MD

Storja ta 'EAHAD u l-Kungress li jmiss

Ippreżentat minn Aislin Ryan, il-Kap Eżekuttiv tal-EAHAD

ISTH Terapija tal-Ġeni għall-Inizjattiva tal-Emofilja u r-Rwol tal-EAHAD

Preżentat minn Flora Peyvandi, MD, PhD

Lura 'l Fuq
Image

Please enable the javascript to submit this form

dwar

Appoġġjati minn għotjiet edukattivi minn Bayer, BioMarin, CSL Behring, Freeline Therapeutics Limited, Pfizer Inc., Spark Therapeutics, u uniQure, Inc.

SSL essenzjali